New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
07:59 EDTIMPVImperva still offers compelling opportunity, says Pacific Crest
After meeting with Imperva's management, Pacific Crest thinks the company's weaker than expected Q1 results were caused by "systemic growing pains," and do not change the company's long-term opportunity. The firm thinks the company has taken steps to fix the problems that caused the Q1 miss, and it reiterates a $35 price target and Outperform rating on the shares.
News For IMPV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2014
13:49 EDTIMPVPalo Alto rallies after results beat expectations
Subscribe for More Information
November 24, 2014
10:00 EDTIMPVOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:14 EDTIMPVImperva initiated with a Buy at Needham
Subscribe for More Information
November 17, 2014
10:02 EDTIMPVOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:48 EDTIMPVState Department hacked, NY Times reports
Subscribe for More Information
05:29 EDTIMPVImperva downgraded to Neutral from Overweight at JPMorgan
JPMorgan downgraded Imperva to Neutral citing the recent outperformance of shares. The firm raised its price target for the stock to $45 from $42.
November 11, 2014
10:00 EDTIMPVOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:19 EDTIMPVBarracuda, Imperva, Palo Alto should be bought, says Pacific Crest
Pacific Crest recommends buying Barracuda (CUDA), Imperva (IMPV), and Palo Alto (PANW), as the firm expects IT security to continue growing strongly. The firm thinks the companies named have compelling margins and free cash flow.
06:36 EDTIMPVImperva initiated with an Outperform at Macquarie
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use